This month marks an exciting milestone for ChezLeon as we prepare to exhibit at the Wounds Australia Conference 2026. Many people know ChezLeon through our first commercial product, the DP-Tx™ Bra Insert, developed to support women experiencing breast lymphoedema following breast cancer treatment. Since its launch, the response from patients and clinicians has reinforced our belief that there is a need for comfortable, practical alternatives that support lymphatic health wi